X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8410) 8410
Book Review (1006) 1006
Publication (733) 733
Newsletter (247) 247
Book Chapter (16) 16
Magazine Article (11) 11
Conference Proceeding (6) 6
Newspaper Article (5) 5
Dissertation (4) 4
Book / eBook (1) 1
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7245) 7245
humans (6265) 6265
male (3038) 3038
female (2891) 2891
microbiology (2819) 2819
infectious diseases (2744) 2744
microbial sensitivity tests (2289) 2289
klebsiella infections - drug therapy (2286) 2286
klebsiella-pneumoniae (2281) 2281
anti-bacterial agents - pharmacology (2236) 2236
anti-bacterial agents - therapeutic use (2213) 2213
klebsiella pneumoniae - drug effects (1993) 1993
middle aged (1951) 1951
aged (1702) 1702
adult (1660) 1660
pharmacology & pharmacy (1660) 1660
escherichia-coli (1543) 1543
antibiotics (1492) 1492
klebsiella (1486) 1486
klebsiella infections - microbiology (1405) 1405
klebsiella pneumoniae (1384) 1384
infections (1369) 1369
bacteria (1351) 1351
enterobacteriaceae (1347) 1347
klebsiella pneumoniae - isolation & purification (1311) 1311
escherichia coli - drug effects (1253) 1253
epidemiology (1132) 1132
drug resistance (1108) 1108
pneumonia (1105) 1105
animals (1072) 1072
beta-lactamases - genetics (965) 965
risk factors (946) 946
drug resistance, bacterial (888) 888
escherichia coli (882) 882
health aspects (878) 878
beta-lactamases - metabolism (870) 870
drug resistance in microorganisms (863) 863
bacterial pneumonia (862) 862
escherichia coli infections - drug therapy (842) 842
resistance (840) 840
mortality (791) 791
gram-negative bacteria (783) 783
research (770) 770
hospitals (762) 762
adolescent (752) 752
risk-factors (739) 739
klebsiella pneumoniae - enzymology (722) 722
klebsiella pneumoniae - genetics (717) 717
prevalence (717) 717
pseudomonas-aeruginosa (716) 716
escherichia coli - isolation & purification (714) 714
drug resistance, multiple, bacterial (713) 713
retrospective studies (707) 707
cross infection - microbiology (680) 680
aged, 80 and over (671) 671
klebsiella infections - epidemiology (664) 664
antimicrobial resistance (662) 662
immunology (661) 661
urinary tract infections - drug therapy (643) 643
nosocomial infections (638) 638
enterobacteriaceae infections - drug therapy (633) 633
treatment outcome (631) 631
bacteremia (628) 628
abridged index medicus (624) 624
antimicrobial agents (605) 605
enterobacteriaceae - drug effects (598) 598
child (592) 592
infection (587) 587
analysis (556) 556
enterobacteriaceae infections - microbiology (556) 556
beta-lactamases - biosynthesis (554) 554
mice (543) 543
pseudomonas aeruginosa - drug effects (541) 541
carbapenems - pharmacology (531) 531
cross infection - drug therapy (527) 527
beta lactamases (524) 524
infectious disease (522) 522
pathogens (518) 518
klebsiella - drug effects (517) 517
escherichia coli infections - microbiology (514) 514
infant, newborn (513) 513
drug resistance, microbial (509) 509
infant (508) 508
bacterial infections - drug therapy (501) 501
child, preschool (488) 488
urinary tract infections - microbiology (488) 488
bacteremia - microbiology (482) 482
bacterial proteins - genetics (481) 481
beta-lactam resistance (471) 471
cross infection - epidemiology (467) 467
anti-bacterial agents - administration & dosage (464) 464
blood-stream infections (463) 463
e coli (463) 463
biochemical phenomena, metabolism, and nutrition (457) 457
emergence (453) 453
medicine, general & internal (448) 448
therapy (447) 447
genes (442) 442
gram-negative bacteria - drug effects (441) 441
bacterial infections and mycoses (436) 436
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7990) 7990
German (129) 129
Japanese (120) 120
Spanish (110) 110
French (106) 106
Russian (59) 59
Italian (38) 38
Chinese (30) 30
Polish (29) 29
Romanian (23) 23
Turkish (12) 12
Korean (9) 9
Dutch (6) 6
Hebrew (4) 4
Portuguese (4) 4
Swedish (4) 4
Czech (3) 3
Norwegian (3) 3
Bulgarian (2) 2
Croatian (2) 2
Danish (2) 2
Afrikaans (1) 1
Hungarian (1) 1
Lithuanian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes | Index Medicus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 7, pp. 726 - 734
Journal Article
Hepatology, ISSN 0270-9139, 05/2012, Volume 55, Issue 5, pp. 1551 - 1561
Epidemiology, risk factors, and clinical effect of infections by multiresistant bacteria in cirrhosis are poorly known. This work was a prospective evaluation... 
PERITONITIS | LIVER-CIRRHOSIS | ACQUIRED INFECTIONS | ESCHERICHIA-COLI | ACQUISITION | RESISTANCE | HEPATORENAL-SYNDROME | SEPSIS | NORFLOXACIN PROPHYLAXIS | GASTROENTEROLOGY & HEPATOLOGY | KLEBSIELLA-PNEUMONIAE | Multivariate Analysis | Prevalence | Prognosis | Community-Acquired Infections - epidemiology | Gram-Positive Bacteria - drug effects | Humans | Middle Aged | Male | Enterobacteriaceae - isolation & purification | Gram-Negative Bacteria - isolation & purification | Liver Cirrhosis - epidemiology | Microbial Sensitivity Tests | Community-Acquired Infections - drug therapy | Drug Resistance, Multiple, Bacterial | Statistics, Nonparametric | Female | Retrospective Studies | beta-Lactamases - metabolism | Bacterial Infections - microbiology | Cross Infection - epidemiology | Liver Cirrhosis - diagnosis | Bacterial Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Risk Factors | Proportional Hazards Models | Cross Infection - drug therapy | Gram-Negative Bacteria - drug effects | Spain - epidemiology | Cross Infection - microbiology | Bacterial Infections - epidemiology | Enterobacteriaceae - drug effects | Survival Analysis | Gram-Positive Bacteria - isolation & purification | Liver Cirrhosis - microbiology | Aged | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Community-Acquired Infections - microbiology | Cohort Studies | Bacterial infections | Antibiotics | Mortality | Bacteria | Staphylococcus infections | Nosocomial infections | Epidemiology | Index Medicus
Journal Article
Infection Control and Hospital Epidemiology, ISSN 0899-823X, 09/2013, Volume 34, Issue 9, pp. 940 - 946
Objective. Urinary tract infections (UTIs) are common among hospitalized patients. Selection of an appropriate antibiotic for this infection requires knowledge... 
Hospitalization rates | Pathogens | Databases | Original Article | Escherichia coli | Urinary tract infections | Hospitalization | Infections | Carbapenems | Klebsiella pneumoniae | Enterobacteriaceae | MORTALITY | INFECTIOUS DISEASES | SINGLE-CENTER EXPERIENCE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ORAL-THERAPY | PYELONEPHRITIS | INTENSIVE-CARE-UNIT | ANTIMICROBIAL THERAPY | ANTIBIOTIC-TREATMENT | PNEUMONIA | NOSOCOMIAL INFECTIONS | PATHOGENS | Escherichia coli Infections - drug therapy | United States - epidemiology | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Humans | Drug Resistance, Bacterial | Escherichia coli Infections - microbiology | Hospitalization - statistics & numerical data | Gram-Negative Bacterial Infections - drug therapy | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Urinary Tract Infections - drug therapy | Gram-Negative Bacterial Infections - microbiology | Escherichia coli Infections - epidemiology | Urinary Tract Infections - epidemiology | Klebsiella Infections - epidemiology | Pseudomonas Infections - epidemiology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Gram-Negative Bacterial Infections - epidemiology | Urinary Tract Infections - microbiology | Cross Infection - epidemiology | Index Medicus | Nursing
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 12/2015, Volume 70, Issue 7, pp. 2133 - 2143
Journal Article
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, ISSN 0098-7484, 09/2018, Volume 320, Issue 10, pp. 984 - 994
IMPORTANCE Extended-spectrum beta-lactamases mediate resistance to third-generation cephalosporins (eg, ceftriaxone) in Escherichia coli and Klebsiella... 
UNITED-STATES | MEDICINE, GENERAL & INTERNAL | EXTENDED-SPECTRUM | CEFEPIME | THERAPY | BACTEREMIA | LACTAMASE-PRODUCING ENTEROBACTERIACEAE | SPECTRUM BETA-LACTAMASES | EXTENSION | Escherichia coli Infections - mortality | Klebsiella pneumoniae - drug effects | Escherichia coli - drug effects | Humans | Middle Aged | Drug Resistance, Bacterial | Bacteremia - mortality | Ceftriaxone - pharmacology | Male | Cause of Death | Anti-Bacterial Agents - therapeutic use | Penicillanic Acid - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Meropenem | Penicillanic Acid - adverse effects | Thienamycins - adverse effects | Penicillanic Acid - analogs & derivatives | Thienamycins - therapeutic use | Escherichia coli Infections - drug therapy | Klebsiella Infections - drug therapy | Piperacillin, Tazobactam Drug Combination | Bacteremia - drug therapy | Piperacillin - adverse effects | Klebsiella Infections - mortality | Aged | Anti-Bacterial Agents - pharmacology | Piperacillin - therapeutic use | Klebsiella | Treatment outcome | Safety and security measures | Tazobactam | Escherichia coli | Patient outcomes | Analysis | Comparative analysis | Risk factors | Bacterial infections | Intravenous administration | Mortality | Clinical trials | Piperacillin-tazobactam | Infections | Ceftriaxone | Drug resistance | Patients | Side effects | Randomization | Cephalosporins | Piperacillin | Drug therapy | Blood diseases | Blood culture | Carbapenems | Index Medicus | Abridged Index Medicus | Original Investigation | Research
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 04/2017, Volume 61, Issue 4
Based upon knowledge of the hydrolytic profile of major-beta-lactamases found in Gram-negative bacteria, we tested the efficacy of the combination of... 
Metallo-β-lactamases | Avibactam | Disk diffusion | Ceftazidime | Aztreonam | GRAM-NEGATIVE INFECTIONS | ceftazidime | aztreonam | avibactam | PENICILLIN-BINDING PROTEINS | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | TIME | disk diffusion | INHIBITORS | metallo-beta-lactamases | KLEBSIELLA-PNEUMONIAE | Azabicyclo Compounds - pharmacology | Enterobacteriaceae - enzymology | Klebsiella pneumoniae - drug effects | Ceftazidime - pharmacology | Humans | Aztreonam - pharmacology | Colony Count, Microbial | Microbial Sensitivity Tests | Neutropenia - complications | beta-Lactamases - genetics | Neutropenia - microbiology | Klebsiella pneumoniae - genetics | Female | Soft Tissue Infections - drug therapy | beta-Lactamases - metabolism | Drug Therapy, Combination | Neutropenia - chemically induced | Enterobacteriaceae - growth & development | Gene Expression | Klebsiella Infections - drug therapy | Drug Administration Schedule | Enterobacteriaceae Infections - microbiology | Thigh | Enterobacteriaceae - genetics | Klebsiella Infections - complications | Klebsiella Infections - microbiology | Plasmids - metabolism | Neutropenia - drug therapy | Soft Tissue Infections - complications | Cyclophosphamide | Animals | Soft Tissue Infections - microbiology | Enterobacteriaceae - drug effects | Klebsiella pneumoniae - enzymology | Plasmids - chemistry | Klebsiella pneumoniae - growth & development | Anti-Bacterial Agents - pharmacology | Mice | beta-Lactam Resistance - genetics | Enterobacteriaceae Infections - drug therapy | beta-Lactam Resistance - drug effects | Index Medicus
Journal Article
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 9/2018, Volume 37, Issue 9, pp. 1627 - 1636
The proportion of antimicrobial resistance (AMR) among the ESKAPE and Escherichia coli (ESKAPEEc) pathogens causing bloodstream infection (BSI) increased... 
Medical Microbiology | Biomedicine | Targeted therapy | Escherichia coli | Bloodstream infections | Internal Medicine | ESKAPE | Antimicrobial resistance | MORTALITY | INFECTIOUS DISEASES | MULTICENTER | MICROBIOLOGY | THERAPY | PREDICTORS | DISSEMINATION | ENTEROBACTERIACEAE | PATHOGENS | Escherichia coli - drug effects | Humans | Escherichia coli Infections - blood | Molecular Targeted Therapy | Incidence | Bacteremia - microbiology | Hospitals, Teaching - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | beta-Lactamases - drug effects | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Bacterial Proteins - drug effects | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Beta lactamases | Health aspects | Public health | Klebsiella | Health care | Pathogens | Communities | Carbapenemase | Antimicrobial agents | Infections | Drug resistance | Antiinfectives and antibacterials | Methicillin | E coli | Pseudomonas aeruginosa | Bacteria | Meropenem | Trends | Ciprofloxacin | Active control | Emergency medical services | Ceftazidime | Index Medicus
Journal Article
Journal Article
Journal Article